Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Novartis AG (Registered) (SWX:NOVN)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Jul 30|
|Day's Range||82.76 - 85.43|
|52 Week Range||70.42 - 86.92|
Novartis AG (Registered) dividends
Novartis AG (Registered) has a market cap or net worth of CHF206.94 billion. The enterprise value is CHF0.
Novartis AG (Registered) has 2.47 billion shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Novartis AG (Registered)'s PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0027%. The beta is 0.0000, so Novartis AG (Registered)'s price volatility has been lower than the market average.
In the last 12 months, Novartis AG (Registered) had revenue of CHF0 and earned CHF0 in profits. Earnings per share was CHF.
Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need.
In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments.
About 110,000 people of more than 140 nationalities work at Novartis around the world..